| EMA number | EMEA/H/C/000630 |
| ATC code | G03BA03 |
| Authorisation | 28 July 2006 |
| Withdrawn | 15 March 2012 |
| Revision | 6 |
Livensa is indicated for the treatment of hypoactive sexual desire disorder (HSDD) in bilaterally oophorectomised and hysterectomised (surgically induced menopause) women receiving concomitant estrogen therapy.